A Buffered Local Anesthetic Without Epinephrine: Development, Characterization, and In Vivo Efficacy and Toxicity Analysis

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2024 Aug 29

PMID 39204403

Authors

Daniel Uzbelger Feldman

Billy B Laun 2nd

Chirag Patel

Sonal V Pande

Sai H S Boddu

Affiliations

Soon will be listed here.

Abstract

Lidocaine hydrochloride (HCl) 2% with 1:100,000 epinephrine (LW/E) is widely used to prevent pain during dental procedures and has been associated with injection sting, jittering effects, slow onset, and a bitter aftertaste. Since LW/E's introduction in 1948, no significant modifications have been proposed. This study aims to design and characterize an improved dental lidocaine HCl injectable formulation without epinephrine (LW/O/E) via buffers, sweeteners, and amino acids. LW/O/E injections were prepared with pH and osmolality values of 6.5-7.0 and 590-610 mOsm/kg. Using the electronic tongue (ETongue), the LW/O/E injectable formulations were characterized for viscosity, injectability, and taste analysis. The results were compared with the LW/E control. In vivo efficacy and anesthetic duration of the samples were measured through radiant heat tail-flick latency (RHTFL) and hot plate (HP) tests and local toxicity was assessed after a single intra-oral injection in Sprague Dawley rats (SDR). The viscosity and injectability values of the LW/O/E samples were found to be comparable to the LW/E injection. ETongue taste analysis showed an improvement in bitterness reduction of the LW/O/E samples compared to the LW/E formulation. Toxicity studies of samples in SDR showed minor and transient signs of erythema/eschar and edema. Anesthetic duration via RHTFL and HP paw withdrawal latency time in SDR were found to be comparable for the LW/O/E Sample 3A and the LW/E injection ( < 0.05). In conclusion, the buffered, higher osmolality and reduced bitterness developed LW/O/E formulation (Sample 3A) could be considered a promising alternative to the LW/E formulation for dental use.

References

Rachid O, Rawas-Qalaji M, Simons K . Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use. Pharmaceutics. 2018; 10(1). PMC: 5874837. DOI: 10.3390/pharmaceutics10010024. View

Crawford S, Niessen L, Wong S, Dowling E . Quantification of patient fears regarding dental injections and patient perceptions of a local noninjectable anesthetic gel. Compend Contin Educ Dent. 2006; 26(2 Suppl 1):11-4. View

Kim H, Hwang K, Yun S, Kim D . Usage of Epinephrine Mixed With Lidocaine in Plastic Surgery. J Craniofac Surg. 2020; 31(3):791-793. DOI: 10.1097/SCS.0000000000006156. View

Bhusal P, Sharma M, Harrison J, Procter G, Andrews G, Jones D . Development, Validation and Application of a Stability Indicating HPLC Method to Quantify Lidocaine from Polyethylene-co-Vinyl Acetate (EVA) Matrices and Biological Fluids. J Chromatogr Sci. 2017; 55(8):832-838. DOI: 10.1093/chromsci/bmx043. View

Kaufman E, Goharian S, Katz Y . Adverse reactions triggered by dental local anesthetics: a clinical survey. Anesth Prog. 2001; 47(4):134-8. PMC: 2149031. View

Wojtalewicz S, Vizmeg J, Erickson S, Lade C, Shea J, Sant H . Evaluating the influence of particle morphology and density on the viscosity and injectability of a novel long-acting local anesthetic suspension. J Biomater Appl. 2022; 37(4):724-736. DOI: 10.1177/08853282221106486. View

Ito E, Ichinohe T, Shibukawa Y, Aida H, Kaneko Y . Anesthetic duration of lidocaine with 10% dextran is comparable to lidocaine with 1:160 000 epinephrine after intraosseous injection in the rabbit. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 104(3):e26-31. DOI: 10.1016/j.tripleo.2007.03.008. View

Bitner D, Uzbelger Feldman D, Axx K, Albandar J . Description and evaluation of an intraoral cervical plexus anesthetic technique. Clin Anat. 2015; 28(5):608-13. DOI: 10.1002/ca.22543. View

Santamaria C, Woodruff A, Yang R, Kohane D . Drug delivery systems for prolonged duration local anesthesia. Mater Today (Kidlington). 2017; 20(1):22-31. PMC: 5621744. DOI: 10.1016/j.mattod.2016.11.019. View

10.

Hocking G, Wildsmith J . Intrathecal drug spread. Br J Anaesth. 2004; 93(4):568-78. DOI: 10.1093/bja/aeh204. View

11.

Agresti C, Tu Z, Ng C, Yang Y, Liang J . Specific interactions between diphenhydramine and alpha-helical poly(glutamic acid)--a new ion-pairing complex for taste masking and pH-controlled diphenhydramine release. Eur J Pharm Biopharm. 2008; 70(1):226-33. DOI: 10.1016/j.ejpb.2008.04.004. View

12.

Mennella J, Spector A, Reed D, Coldwell S . The bad taste of medicines: overview of basic research on bitter taste. Clin Ther. 2013; 35(8):1225-46. PMC: 3772669. DOI: 10.1016/j.clinthera.2013.06.007. View

13.

Kohli K, Ngan P, Crout R, Linscott C . A survey of local and topical anesthesia use by pediatric dentists in the United States. Pediatr Dent. 2001; 23(3):265-9. View

14.

Arora G, Degala S, Dasukil S . Efficacy of buffered local anaesthetics in head and neck infections. Br J Oral Maxillofac Surg. 2019; 57(9):857-860. DOI: 10.1016/j.bjoms.2019.06.021. View

15.

Bader J, Bonito A, Shugars D . A systematic review of cardiovascular effects of epinephrine on hypertensive dental patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93(6):647-53. DOI: 10.1067/moe.2002.123866. View

16.

Malamed S, Tavana S, Falkel M . Faster onset and more comfortable injection with alkalinized 2% lidocaine with epinephrine 1:100,000. Compend Contin Educ Dent. 2013; 34 Spec No 1:10-20. View

17.

Gaffar B, Alagl A, Al-Ansari A . The prevalence, causes, and relativity of dental anxiety in adult patients to irregular dental visits. Saudi Med J. 2014; 35(6):598-603. View

18.

Harbert H . Counteracting the bitter taste of local anesthetic. J Am Dent Assoc. 2001; 132(10):1418-9. DOI: 10.14219/jada.archive.2001.0057. View

19.

Un I, Kurt A, Buyukafsar K . Hyperosmolar glucose induces vasoconstriction through Rho/Rho-kinase pathway in the rat aorta. Fundam Clin Pharmacol. 2011; 27(3):244-51. DOI: 10.1111/j.1472-8206.2011.01014.x. View

20.

Cram A, Breitkreutz J, Desset-Brethes S, Nunn T, Tuleu C . Challenges of developing palatable oral paediatric formulations. Int J Pharm. 2008; 365(1-2):1-3. DOI: 10.1016/j.ijpharm.2008.09.015. View